$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] A three-dimensional hyaluronic acid-based niche enhances the therapeutic efficacy of human natural killer cell-based cancer immunotherapy

Biomaterials, v.247, 2020년, pp.119960 -   

Ahn, Young Ha (Immunotherapy Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB)) ,  Ren, Long (SKKU Advanced Institute of Nanotechnology (SAINT), Department of Nano Engineering, and School of Chemical Engineering, Sungkyunkwan University) ,  Kim, Seok Min (Immunotherapy Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB)) ,  Seo, Sang-Hwan (Immunotherapy Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB)) ,  Jung, Cho-Rok (Stem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB)) ,  Kim, Da Seul (Immunotherapy Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB)) ,  Noh, Ji-Yoon (Immunotherapy Convergence Research Center, Korea Research Institute of Bioscience and B) ,  Lee, Soo Yun ,  Lee, Hyunseung ,  Cho, Mi Young ,  Jung, Haiyoung ,  Yoon, Suk Ran ,  Kim, Jung-Eun ,  Lee, Sang Nam ,  Kim, Sohyun ,  Shin, Il Woo ,  Shin, Hong Sik ,  Hong, Kwan Soo ,  Lim, Yong Taik ,  Choi, Inpyo ,  Kim, Tae-Don

Abstract AI-Helper 아이콘AI-Helper

Abstract Adoptive transfer of natural killer (NK) cells is becoming one of the most important parts of cancer immunotherapy. However, recent accomplishments have focused on the improvement of the targeting effects based on the engineering of chimeric antigen receptors (CARs) on cell surfaces. Despi...

Keyword

참고문헌 (46)

  1. Nature Mellman 480 480 2011 10.1038/nature10673 Cancer immunotherapy comes of age 

  2. Nat. Rev. Canc. Pardoll 12 252 2012 10.1038/nrc3239 The blockade of immune checkpoints in cancer immunotherapy 

  3. Nat. Rev. Canc. Rosenberg 8 299 2008 10.1038/nrc2355 Adoptive cell transfer: a clinical path to effective cancer immunotherapy 

  4. Nat. Med. Rosenberg 10 909 2004 10.1038/nm1100 Cancer immunotherapy: moving beyond current vaccines 

  5. Curr. Pharmaceut. Biotechnol. Androulla 19 5 2018 10.2174/1389201019666180418095526 CAR T-cell therapy: a new era in cancer immunotherapy 

  6. N. Engl. J. Med. Rosenbaum 377 1313 2017 10.1056/NEJMp1711886 Tragedy, perseverance, and chance - the story of CAR-T therapy 

  7. Nat. Rev. Clin. Oncol. Brudno 15 31 2017 10.1038/nrclinonc.2017.128 Chimeric antigen receptor T-cell therapies for lymphoma 

  8. Nat. Rev. Clin. Oncol. Jackson 13 370 2016 10.1038/nrclinonc.2016.36 Driving CAR T-cells forward 

  9. NK Cells in Therapy of Cancer Bachanova 19 133 2014 

  10. Nat. Rev. Immunol. Chiossone 18 671 2018 10.1038/s41577-018-0061-z Natural killer cells and other innate lymphoid cells in cancer 

  11. Immunol. Rev. Moretta 224 58 2008 10.1111/j.1600-065X.2008.00651.x Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias 

  12. Nat. Rev. Immunol. O'Brien 19 282 2019 10.1038/s41577-019-0139-2 Immunometabolism and natural killer cell responses 

  13. Cell. Mol. Immunol. Habif 16 415 2019 10.1038/s41423-019-0224-2 Targeting natural killer cells in solid tumors 

  14. Canc. Discov. Melero 4 522 2014 10.1158/2159-8290.CD-13-0985 T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious cancer immunotherapy 

  15. Front Oncol Nayyar 9 51 2019 10.3389/fonc.2019.00051 Overcoming resistance to natural killer cell based immunotherapies for solid tumors 

  16. Frontiers in Oncology Koehl 3 2013 10.3389/fonc.2013.00118 Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocol 

  17. OncoImmunology Koehl 5 e1115178 2016 10.1080/2162402X.2015.1115178 Advances in clinical NK cell studies: donor selection, manufacturing and quality control 

  18. Hum. Gene Ther. Stephan 28 897 2017 10.1089/hum.2017.157 Optimization of human NK cell manufacturing: fully automated separation, improved ex vivo expansion using IL-21 with autologous feeder cells, and generation of anti-cd123-CAR-expressing effector cells 

  19. Acta Pharmacol. Sin. Hu 39 167 2017 10.1038/aps.2017.125 Chimeric antigen receptor (CAR)-transduced natural killer cells in tumor immunotherapy 

  20. Leukemia Liu 32 520 2017 10.1038/leu.2017.226 Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity 

  21. Haycock 1 2011 3D Cell Culture: Methods and Protocols 3D cell culture: a review of current approaches and techniques 

  22. Tissue Eng. B Rev. Fan 23 451 2017 10.1089/ten.teb.2016.0465 Macroporous hydrogel scaffolds for three-dimensional cell culture and tissue engineering 

  23. Sci. Rep. Kim 7 40623 2017 10.1038/srep40623 Multi-cellular natural killer (NK) cell clusters enhance NK cell activation through localizing IL-2 within the cluster 

  24. Br. J. Ophthalmol. Gomes 88 821 2004 10.1136/bjo.2003.027573 Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro 

  25. Investig. Ophthalmol. Vis. Sci. Inoue 34 2313 1993 The effect of hyaluronic acid on corneal epithelial cell proliferation 

  26. Adv. Funct. Mater. Ren 28 1804490 2018 10.1002/adfm.201804490 Degradation-regulatable Architectured implantable macroporous scaffold for the spatiotemporal modulation of immunosuppressive microenvironment and enhanced combination cancer immunotherapy 

  27. Sci. Rep. Kim 7 40623 2017 10.1038/srep40623 Multi-cellular natural killer (NK) cell clusters enhance NK cell activation through localizing IL-2 within the cluster 

  28. Sci. Rep. Kim 4 7157 2014 10.1038/srep07157 Homotypic NK cell-to-cell communication controls cytokine responsiveness of innate immune NK cells 

  29. Mol. Canc. Ertel 5 55 2006 10.1186/1476-4598-5-55 Pathway-specific differences between tumor cell lines and normal and tumor tissue cells 

  30. Cancer Epidemiology Liu 37 930 2013 10.1016/j.canep.2013.08.011 Genetic variations in CTLA-4, TNF-α, and LTA and susceptibility to T-cell lymphoma in a Chinese population 

  31. J. Immunol. Luger 143 1206 1989 10.4049/jimmunol.143.4.1206 IFN-beta 2/IL-6 augments the activity of human natural killer cells 

  32. J. Neuro Oncol. Whiteway 111 113 2013 10.1007/s11060-012-1000-7 Inhibition of cyclin-dependent kinase 6 suppresses cell proliferation and enhances radiation sensitivity in medulloblastoma cells 

  33. Nat. Immunol. Bezman 13 1000 2012 10.1038/ni.2395 Molecular definition of the identity and activation of natural killer cells 

  34. J. Thorac. Dis. Su 6 949 2014 Prognostic factors in patients with recurrence after complete resection of esophageal squamous cell carcinoma 

  35. Transl. Lung Cancer Res. Uramoto 3 242 2014 Recurrence after surgery in patients with NSCLC 

  36. Nat. Rev. Mater. Dellacherie 4 379 2019 10.1038/s41578-019-0106-3 Macroscale biomaterials strategies for local immunomodulation 

  37. Canc. Res. Liu 75 3596 2015 10.1158/0008-5472.CAN-15-0159 Affinity-tuned ErbB2 or EGFR chimeric antigen receptor T cells exhibit an increased therapeutic index against tumors in mice 

  38. Cancer Control Rocha-Lima 14 295 2007 10.1177/107327480701400313 EGFR targeting of solid tumors 

  39. Immunol. Cell Biol. Yong 95 356 2017 10.1038/icb.2016.128 CAR T-cell therapy of solid tumors 

  40. Curr. Opin. Immunol. Chen 51 103 2018 10.1016/j.coi.2018.03.002 Driving CARs on the uneven road of antigen heterogeneity in solid tumors 

  41. Immunotherapy Geller 3 1445 2011 10.2217/imt.11.131 Use of allogeneic NK cells for cancer immunotherapy 

  42. Front. Immunol. Gras Navarro 6 2015 10.3389/fimmu.2015.00202 Therapeutic potential and challenges of natural killer cells in treatment of solid tumors 

  43. Immunotherapy Iliopoulou 59 1781 2010 A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer, Cancer Immunology 

  44. J. Innate Immunity Stojanovic 3 355 2011 10.1159/000325465 Natural killer cells and solid tumors 

  45. Childs 234 2013 Bringing Natural Killer Cells to the Clinic: Ex Vivo Manipulation 

  46. Cytotherapy Lapteva 14 1131 2012 10.3109/14653249.2012.700767 Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications 

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로